No price change in 78% of actively used drugs post GST: NPPA
Drug pricing regulator NPPA said prices of around 78 per cent of 'actively used and traded' drugs will remain unaffected after the rollout of the Goods and Services Tax. NPPA has already announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotics, with a majority being reduced ahead of the GST implementation. These prices will be notified as formal revised ceiling prices immediately after GST notification...
G●●●●m V●●●a and 36 others like this3 shares